Caixin
Jun 28, 2022 03:10 PM
BUSINESS

Biotech Startup Mirxes Weighs $300 Million Singapore IPO

New economies are a rarity on the Singapore Exchange, known as a regional hub for real estate trusts. Photo: Bloomberg
New economies are a rarity on the Singapore Exchange, known as a regional hub for real estate trusts. Photo: Bloomberg

(Bloomberg) — Mirxes Pte., a Singapore-based biotechnology startup, is weighing an initial public offering in the city-state next year that could raise about $300 million, according to people with knowledge of the matter.

The company is in discussions with bankers about a potential offering that could value it at over $1 billion, said the people, who asked not to be identified as the process is private.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code